Physician profile
Ankur Jain
NPI 1598098782
$24,108.26
in general payments reported to CMS, 2019-2025
29 companies · $2,690 in 2025
The $2,690 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $7,444 · 2021: $318 · 2022: $5,041 · 2023: $4,117 · 2024: $3,755 · 2025: $2,690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,222 · Travel and Lodging: $3,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,221.93 |
| Travel and Lodging | $3,339.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,665.87 | 2019-2025 | Amplatzer Amulet, Triclip, Mitraclip |
| Abiomed | $3,683.78 | 2019-2025 | Impella |
| Penumbra, INC. | $3,575.05 | 2022-2025 | Indigo System, Penumbra System, Smart Coil |
| Medtronic Vascular, INC. | $1,904.50 | 2020 | |
| Boston Scientific Corporation | $719.64 | 2019-2024 | Rotapro, Synergy, Watchman |
| Cardiva Medical, INC. | $607.72 | 2022-2025 | Optowire, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Shockwave Medical, INC | $534.68 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Medtronic, INC. | $526.58 | 2021-2025 | Venaseal, Abre, Cobalt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $392.76 | 2022-2023 | Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $290.61 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $273.88 | 2019-2025 | |
| Amgen INC. | $273.09 | 2022-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $251.25 | 2019-2024 | Xarelto |
| Pfizer INC. | $183.35 | 2022-2024 | |
| Cardiovascular Systems INC. | $172.81 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $124.99 | 2023 | |
| Zoll Circulation INC | $119.80 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $119.13 | 2023-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.18 | 2019-2025 | Lifevest |
| Stryker Corporation | $112.82 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Recor Medical INC | $108.20 | 2024 | Paradise Renal Denervation System |
| Elutia, INC. | $98.56 | 2020 | |
| Janssen Biotech, INC. | $78.49 | 2025 | Tremfya |
| Cook Medical LLC | $55.29 | 2025 | Rosen, Micropuncture |
| Merck Sharp & Dohme LLC | $38.70 | 2023-2025 | Verquvo |
| Kestra Medical Technology Services, INC. | $25.79 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $24.63 | 2022 | |
| Teleflex LLC | $17.36 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $12.75 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.